InvestSMART

Proteomics International Laboratories Ltd (ASX: PIQ) - Announcements

Current share price for PIQ : $0.160 0.015 (8.57%)+

ASX company news and announcements for Proteomics International Laboratories Ltd (PIQ) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Proteomics International Laboratories Ltd (PIQ) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Proteomics International Laboratories Ltd (PIQ), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Proteomics International Laboratories Ltd (PIQ)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$26 Esophageal cancer test results presented at World Congress 19 Sep 2025 8:38AM $0.335 $0.155 fallen by 53.73%
$26 Proteomics granted certification for Diagnostics Laboratory 18 Sep 2025 8:26AM $0.290 $0.155 fallen by 46.55%
$26 Notice of AGM Date 16 Sep 2025 3:36PM $0.295 $0.155 fallen by 47.46%
$26 Board and Management Transition 9 Sep 2025 8:53AM $0.320 $0.155 fallen by 51.56%
$26 PromarkerEso precisely detects early stage esophageal cancer 8 Sep 2025 8:36AM $0.305 $0.155 fallen by 49.18%
$26 Annual Report to Shareholders 27 Aug 2025 9:12AM $0.320 $0.155 fallen by 51.56%
$26 Appendix 4G and Corporate Governance Statement 27 Aug 2025 9:06AM $0.320 $0.155 fallen by 51.56%
$26 Preliminary Final Report 27 Aug 2025 9:05AM $0.320 $0.155 fallen by 51.56%
$26 Quarterly Activities/Appendix 4C Cash Flow Report 28 Jul 2025 8:43AM $0.395 $0.155 fallen by 60.76%
$26 Next-Gen PromarkerD test performance results published 24 Jul 2025 1:32PM $0.385 $0.155 fallen by 59.74%
$26 OxiDx test detects muscle damage in thoroughbred racehorses 14 Jul 2025 8:19AM $0.470 $0.155 fallen by 67.02%
$26 Application for quotation of securities - PIQ 8 Jul 2025 9:01AM $0.395 $0.155 fallen by 60.76%
$26 Notification of cessation of securities - PIQ 7 Jul 2025 3:43PM $0.410 $0.155 fallen by 62.20%
$26 Top 20 Holders and Range of Units for Attaching Options 4 Jul 2025 12:03PM $0.415 $0.155 fallen by 62.65%
$26 Application for quotation of securities - PIQ 4 Jul 2025 11:59AM $0.420 $0.155 fallen by 63.10%
$26 AMA grants reimbursement code for Next-Gen PromarkerD test 3 Jul 2025 8:20AM $0.355 $0.155 fallen by 56.34%
$26 Funding boost for precision diagnostics Proteomics Facility 1 Jul 2025 8:30AM $0.325 $0.155 fallen by 52.31%
$26 First patent for endometriosis blood test - granted in Japan 30 Jun 2025 8:24AM $0.290 $0.155 fallen by 46.55%
$26 Next-gen PromarkerD test system released for predicting DKD 23 Jun 2025 8:19AM $0.360 $0.155 fallen by 56.94%
$26 PromarkerD launched into the US at major diabetes conference 20 Jun 2025 8:36AM $0.355 $0.155 fallen by 56.34%
$26 Change of Director's Interest Notices x 4 13 Jun 2025 9:23AM $0.385 $0.155 fallen by 59.74%
$26 Notice Under Section 708A 10 Jun 2025 2:41PM $0.400 $0.155 fallen by 61.25%
$26 Notification regarding unquoted securities - PIQ 6 Jun 2025 9:56AM $0.410 $0.155 fallen by 62.20%
$26 Notification regarding unquoted securities - PIQ 6 Jun 2025 9:54AM $0.410 $0.155 fallen by 62.20%
$26 Notification regarding unquoted securities - PIQ 6 Jun 2025 9:53AM $0.410 $0.155 fallen by 62.20%

51 - 75 of 684 results

Page 3 of 28

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.